Managing sickle cell disease through increased adoption of hydroxyurea in nigeria (ACCELERATE)
Active Cooperative Agreement Awarded Last action
- Award ID
- U01HL168084
- Recipient
-
New York University UEI NX9PXMKW5KW8
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,867,560
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 65% complete
- Place of performance
- New York, NY 10012, USA
Award details come from USAspending.gov.
Description
- Abstract
- Large knowledge gaps remain regarding strategies to promote the adoption of hydroxyurea (HU), particularly in sub-saharan african countries including nigeria, where more than 75% of annual sickle cell anemia births occur. The vast majority of people with SCD in africa do not receive evidenced-based health care (e.g., newborn screening, health education, prophylaxis for infection, optimal nutrition and hydration, blood transfusion, transcranial doppler screening, and HU therapy), despite its effectiveness in reducing SCD-related adverse outcomes and mortality. The use of HU in SSA is
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $227,383 | |
| Amendment | $438,160 | |
| Amendment | $227,383 | |
| Amendment | $448,464 | |
| Amendment | $671,166 | |
| Amendment | $708,422 | |
| Original award | $708,422 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| University Of Abuja | $910,396 |
Quick answers
Who received award U01HL168084?
U01HL168084 was awarded to New York University by National Heart Lung and Blood Institute (National Institutes of Health) on August 15, 2023.
How much is award U01HL168084 worth?
$3,867,560 has been obligated on U01HL168084.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award